265 related articles for article (PubMed ID: 30268919)
1. Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment.
He F; Shi Q; Fu Y; Xu J; Yu Y; Du X
Infect Genet Evol; 2018 Dec; 66():188-191. PubMed ID: 30268919
[TBL] [Abstract][Full Text] [Related]
2. Emergence of a Fatal ST11-KL64 Tigecycline-Resistant Hypervirulent Klebsiella pneumoniae Clone Cocarrying
Huang J; Yi M; Yuan Y; Xia P; Yang B; Liao J; Dang Z; Luo S; Xia Y
Microbiol Spectr; 2022 Dec; 10(6):e0253922. PubMed ID: 36205391
[TBL] [Abstract][Full Text] [Related]
3. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
[TBL] [Abstract][Full Text] [Related]
4. Resistance evolution of hypervirulent carbapenem-resistant
Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
[TBL] [Abstract][Full Text] [Related]
5. Molecular Epidemiology of Plasmid-Mediated Fosfomycin Resistance Gene Determinants in Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Isolates in China.
Chen J; Wang D; Ding Y; Zhang L; Li X
Microb Drug Resist; 2019 Mar; 25(2):251-257. PubMed ID: 30113251
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection.
Bi S; Yao X; Huang C; Zheng X; Xuan T; Sheng J; Xu K; Zheng B; Yang Q
Infection; 2019 Jun; 47(3):497-500. PubMed ID: 30734249
[TBL] [Abstract][Full Text] [Related]
7. Draft genome sequence of a tigecycline-resistant KPC-2-producing Klebsiella pneumoniae ST15 clinical isolate from China.
Xu J; Gao M; Hong Y; He F
J Glob Antimicrob Resist; 2017 Dec; 11():156-158. PubMed ID: 29101083
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
Tian Y; Zhang Q; Wen L; Chen J
Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
[TBL] [Abstract][Full Text] [Related]
10. Roles of
Chiu SK; Huang LY; Chen H; Tsai YK; Liou CH; Lin JC; Siu LK; Chang FY; Yeh KM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533243
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae isolates.
Park Y; Choi Q; Kwon GC; Koo SH
J Clin Lab Anal; 2020 Dec; 34(12):e23506. PubMed ID: 32815626
[TBL] [Abstract][Full Text] [Related]
12. The Resistance Mechanism and Clonal Distribution of Tigecycline-Nonsusceptible Klebsiella pneumoniae Isolates in Korea.
Ahn C; Yoon SS; Yong TS; Jeong SH; Lee K
Yonsei Med J; 2016 May; 57(3):641-6. PubMed ID: 26996563
[TBL] [Abstract][Full Text] [Related]
13. Characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Fuzhou, China.
Chen D; Li H; Zhao Y; Qiu Y; Xiao L; He H; Zheng D; Li X; Huang L; Yu X; Xu N; Hu X; Chen Y; Chen F
J Appl Microbiol; 2020 Nov; 129(5):1220-1226. PubMed ID: 32396222
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem.
Wang ZQ; Guo ZL; Feng H; Fu C; Zhao GY; Ma K; Zhu L; Chen G
Curr Med Sci; 2021 Aug; 41(4):770-776. PubMed ID: 34403102
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
[TBL] [Abstract][Full Text] [Related]
16. Development of Tigecycline Resistance in Carbapenemase-Producing
Yoon EJ; Oh Y; Jeong SH
Ann Lab Med; 2020 Jan; 40(1):15-20. PubMed ID: 31432634
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
Papadimitriou-Olivgeris M; Bartzavali C; Spyropoulou A; Lambropoulou A; Sioulas N; Vamvakopoulou S; Karpetas G; Spiliopoulou I; Vrettos T; Anastassiou ED; Fligou F; Christofidou M; Marangos M
Diagn Microbiol Infect Dis; 2018 Nov; 92(3):235-240. PubMed ID: 30076041
[TBL] [Abstract][Full Text] [Related]
18. In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
Lin YT; Huang YW; Huang HH; Yang TC; Wang FD; Fung CP
Int J Antimicrob Agents; 2016 Nov; 48(5):485-491. PubMed ID: 27575728
[TBL] [Abstract][Full Text] [Related]
19. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
[TBL] [Abstract][Full Text] [Related]
20. Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant
Han X; Shi Q; Mao Y; Quan J; Zhang P; Lan P; Jiang Y; Zhao D; Wu X; Hua X; Yu Y
Front Cell Infect Microbiol; 2021; 11():757470. PubMed ID: 34760723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
